Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia.
about
Innate lymphocyte cells in asthma phenotypesInsights into Group 2 Innate Lymphoid Cells in Human Airway DiseaseAspirin-exacerbated respiratory disease: Prevalence, diagnosis, treatment, and considerations for the futureDevelopments in the field of clinical allergy in 2015 through the eyes of Clinical and Experimental Allergy.Chronic rhinosinusitis phenotypes.Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease.Emerging Endotypes of Chronic Rhinosinusitis and Its Application to Precision Medicine.Air Pollution and Climate Change Effects on Allergies in the Anthropocene: Abundance, Interaction, and Modification of Allergens and Adjuvants.Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis.Barrier function of the nasal mucosa in health and type-2 biased airway diseases.Current and future biomarkers in allergic asthma.Allergen-Dependent Differences in ILC2s Frequencies in Patients With Allergic RhinitisLeukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s.Innate lymphoid cells are pivotal actors in allergic, inflammatory and autoimmune diseases.Group 2 innate lymphoid cells in disease.Innate lymphoid cells in intestinal immunity and inflammation.Role of Eosinophil Granulocytes in Allergic Airway Inflammation Endotypes.Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis.Type two innate lymphoid cells: the Janus cells in health and disease.IL-33: biological properties, functions, and roles in airway disease.Effects of thermal water inhalation in chronic upper respiratory tract infections in elderly and young patients.Classification of chronic rhinosinusitis according to a nasal polyp and tissue eosinophilia: limitation of current classification system for Asian population.Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps.Role of group 2 innate lymphocytes in aspirin-exacerbated respiratory disease pathogenesis.Comorbid "treatable traits" in difficult asthma: Current evidence and clinical evaluation.Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications.Pathological and therapeutic roles of innate lymphoid cells in diverse diseases.Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease.Local IL-25 contributes to Th2-biased inflammatory profiles in nasal polyps.Prostaglandin E2 suppresses human group 2 innate lymphoid cell function.Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities.ILC2 frequency and activity are inhibited by glucocorticoid treatment via STAT pathway in patients with asthma.Activation of group 2 innate lymphoid cells exacerbates and confers corticosteroid resistance to mouse nasal type 2 inflammation.Pathogenesis of Recalcitrant Chronic Rhinosinusitis: The Emerging Role of Innate Immune Cells.Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis.Biomarkers in Chronic Rhinosinusitis with Nasal PolypsThe impact of allergen exposure and specific immunotherapy on circulating blood cells in allergic rhinitisChanges of TNF-α, PDGF and HA in nasal secretions and olfactory function of patients with chronic sinusitis before and after endoscopic sinus surgery
P2860
Q27010139-7F75EE69-FA15-4151-ABC1-12CFEC6744C6Q28076134-BEFF9ED7-281B-4A51-8F92-116D0A69820EQ30238776-02DA6688-2EFB-4FB5-82CC-DECE6A18B529Q30243994-CA8AD239-C80F-44FC-B681-E08B1470F220Q30275962-87E7CCEA-C0D9-4AF7-93C8-A34E388BAEB9Q30276354-2F8D1EF1-5D67-4DF1-ADB5-48D9A48A7E0BQ33734329-E29D245B-934C-4BC8-8F98-F7E601F34A75Q33752095-01FB2FE7-8BBA-44ED-9178-BDE1D96F5216Q33913202-319BBE6F-B2E2-4166-BDF4-90CB31185417Q35852413-D246D832-1F85-4112-851E-C73AA8BB2C7AQ35878914-0158F285-9FBF-4BCE-8C81-76BFE7B3902EQ36636578-B0977E00-D3C2-4843-919B-3D6869C15021Q37549767-8BF3632E-C014-43C2-90FC-DA39F3399CDEQ38500621-BFF66998-C841-4294-9750-78BE89A61DCFQ38573631-864011F5-B6B1-463D-8763-86D3255BA890Q38605374-374CFD8D-2A4E-4E96-AFDB-FAC0D94F95A3Q38831891-A738A506-60F3-4C69-AC1D-A0F1175AAC36Q38973949-03644A66-238D-42A0-97E7-8429E97EF86FQ39402904-4B553596-F002-4B0E-B38B-44F744B9EBC9Q39402943-4DBEA26F-882B-47B1-B121-2AC74D288287Q39789703-76C2D8A9-BF1E-4604-914B-4C159BF0BF66Q41190514-9A59EB3E-D1D6-44CD-B97D-102BAD6D268AQ41506242-0503D35C-2486-4290-A6A3-6E84B4630B5FQ47656375-92B7361F-290C-4A89-A2F2-4BFCFCF42A93Q47659621-2C98617A-9E3D-41EF-852A-851E19DE98E6Q47719552-0E7001AB-AC7C-4541-B37A-801BC9958E17Q47897160-64837B88-2307-488A-939D-8E309E7E4CCEQ47964479-BAFFB4F7-DE59-49E5-A0C5-5FBD9203F37BQ47995108-DBB6041E-B29F-4ECB-BA7F-2E01BB9AD804Q50025252-9C0215C7-5CFC-4A6E-B306-5B6E6A986C48Q52643512-1DCFB229-EDD6-4D4A-80C2-FDF5AB0B0AECQ52654725-4B2FC350-09F2-4FE3-A203-0C1950FD7B11Q53738990-57158976-F452-4ADF-8701-8B02E08F4957Q55242373-B1335535-548E-4B3D-84E4-63F8FB075D5CQ55403212-0C0D0A5F-DED2-4A07-A9C1-CD8BE289BB71Q57787275-44CB6DBC-7398-4E61-A625-2230B565B9F4Q58611597-F559355C-5C44-4F9D-A6E2-70AC8FF4DD90Q58767715-1ADE8B17-0327-4C0B-A7EE-5872337B8728
P2860
Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Group 2 innate lymphoid cells ...... nasal polyps or eosinophilia.
@en
Group 2 innate lymphoid cells
@nl
type
label
Group 2 innate lymphoid cells ...... nasal polyps or eosinophilia.
@en
Group 2 innate lymphoid cells
@nl
prefLabel
Group 2 innate lymphoid cells ...... nasal polyps or eosinophilia.
@en
Group 2 innate lymphoid cells
@nl
P2093
P2860
P356
P1476
Group 2 innate lymphoid cells ...... h nasal polyps or eosinophilia
@en
P2093
P2860
P304
P356
10.1111/CEA.12462
P577
2015-02-01T00:00:00Z